PHR — Phreesia, Inc.

Summary of Phreesia, Inc. Q4 2026 Earnings Call

1. Key Financial Results and Metrics

• Q4 Revenue: $127.1 million, a 16% increase year-over-year; 7% growth excluding the AccessOne acquisition.
• Adjusted EBITDA: $29.4 million, up from $16.4 million year-over-year, with a margin of 23%.
• Average Healthcare Services Clients (AHSCs): 4,658, an increase of 138 from the previous quarter, with 80 from AccessOne.
• Total Revenue per AHSC: $27,279, an 8% year-over-year increase.
• Free Cash Flow: $28.5 million, a record high, up $19.3 million year-over-year.
• Net Income: Achieved positive GAAP net income for the first time in company history.

2. Strategic Updates and Business Highlights

• Acquisition of AccessOne: Central to provider financing strategy, enhancing cash flow predictability for providers amid rising patient financial responsibility.
• Launch of ProviderConnect: Aimed at healthcare provider marketers, complementing the existing PatientConnect offering.
• AI Integration: Increasing use of AI for operational efficiencies and margin expansion, with a focus on reducing manual processes and reliance on outsourced resources.
• Financial Profile: Positioned for growth with a strong balance sheet, allowing flexibility for future opportunities.

3. Forward Guidance and Outlook

• Fiscal Year 2027 Revenue Guidance: Revised down to $510 million - $520 million from a prior range of $545 million - $559 million, reflecting reduced visibility into spending commitments from certain pharmaceutical manufacturers.
• Adjusted EBITDA Guidance: Maintained at $125 million - $135 million, indicating confidence in operational leverage despite revenue reductions.
• AHSC Growth Expectation: Mid-single-digit percentage growth anticipated for fiscal 2027.

4. Bad News, Challenges, or Points of Concern

• Network Solutions Revenue Variability: Shorter visibility into spending commitments from pharmaceutical clients, particularly in specific brands and therapeutic areas (e.g., vaccines and public health).
• Market Challenges: The healthcare industry is facing broader challenges, including FDA guidelines and provider reimbursement issues, impacting revenue visibility.
• Potential for Revenue Decline: The guidance suggests a possible year-over-year decline in Network Solutions revenue, particularly in the second half of fiscal 2027.

5. Notable Q&A Insights

• Client Spending Dynamics: The reduction in revenue guidance is not broad-based but specific to certain brands and therapeutic areas. There is fluidity in client budgets, with potential for adjustments later in the fiscal year.
• ProviderConnect Contribution: While the launch was positive, it is still in early stages and not expected to significantly offset weaknesses in Network Solutions.
• AI Impact on Costs: The company is focused on efficiency gains through AI, with expectations for improved margins and reduced reliance on manual processes.
• Competitive Landscape: Phreesia remains confident in its differentiated value proposition, particularly in providing valuable content to patients and providers, despite external pressures.

This summary encapsulates the key points from Phreesia's Q4 2026 earnings call, highlighting both the achievements and the challenges ahead as the company navigates a complex healthcare landscape.